RMC_Banner

 

Learn more about Renal Medullary Cancer by listening to MD Anderson’s Dr. Pavlos Msaouel here.

 

And watch Lead Moderator, Ritchie Johnson on GMA3 in June 2021

 

AnCan and The Chris “CJ” Johnson RMC Foundation come together to provide support for the Renal Medullary Carcinoma (‘RMC’) community by hosting video chat, peer moderated virtual groups. RMC is a rare type of kidney cancer associated with Sickle Cell Trait (SCT) or Sickle Cell Disease (SCD).

The Chris “CJ” Johnson Foundation Inc., established in 2013 by Ritchie Johnson in memory of her son, Chris, who passed away in 2012. We are a 501(c)3 non-profit organization based in Sugar Land, Texas.  Our primary focus is to identify individuals with sickle hemoglobinopathies such as sickle cell trait (SCT), who may be at risk for renal medullary carcinoma (RMC), a rare and aggressive form of kidney cancer. We offer programs that heighten awareness, educate and promote advocacy to increase public understanding, and ultimately a cure for RMC.  Additionally, the foundation donates annually to University of Texas MD Anderson Cancer Center located in Houston, Texas to advance RMC research.

Our mission is to be a global community dedicated to creating awareness and alleviating healthcare disparities for individuals diagnosed with RMC through advocacy, education and research. Ultimately, all persons affected with RMC will have equal access to institutions that are leaders in cutting-edge research.

Our vision is to eliminate healthcare disparities and find a cure for renal medullary carcinoma (RMC).

To read more about our US and Global partner, The Chris “CJ” Johnson RMC Foundation and their Founder, Ritchie Johnson, please visit their website and their Facebook page.

To read more about our UK partner, The Ricky Casey Trust  and their Founder, Nicola Forshaw Casey , please visit theirwebsite and their Facebook page.

Our sessions may be recorded and posted to AnCan’s YouTube Channel, shared on social media and elsewhere.

The video chat virtual group meets on 2nd Tuesdays of the month at 8 pm Eastern, 7 pm Central, 6 pm Mountain and 5 pm Pacific in the AnCan Schmier Room. You can join online or by phone at +1 646 749 3127 Access # 656-182-845. See the Joining Instructions Panel above right for more information and other Country Access codes.  

Instructions for Joining a Group

 

Click HERE to learn how to connect with your computer or phone. No downloads required.


Click HERE to sign up for email reminders on virtual groups that interest you.

All of our groups are FREE...

and you can drop in at any time!

Quick Links

 

 Click HERE for a complete list of resources

The Chris ‘CJ’ Johnson Foundation

The Ricky Casey Trust 

 

Upcoming RMC Groups

Renal Medullary Carcinoma

Our moderators are patients and caregivers who intimately understand the struggles associated with RMC.  We aspire to come together to give strength, bring encouragement, and provide support to patients and caregivers from all over the world. This is a peer-moderated group. As such, we cannot provide medical advice; we can speak about our own experiences with RMC. We are here for you, and look forward to meeting you! Moderator bios are found below.

Meet our moderators

Andre Snead headshot
Renal Medullary Carcinoma Patient
In 2019, I was diagnosed with Renal Medullary Carcinoma (RMC), a rare and aggressive form of kidney cancer.
Moderator and Advocate
through AnCan, she proudly wears the ‘Advocate Hat’ for all!
Charissa Moran
Renal Medullary Carcinoma Caregiver
Charissa Moran’s late husband, Carlos Moran was diagnosed with Renal Medullary Carcinoma in December 2016, 6 months after they got married.
Ritchie Johnson Headshot
Renal Medullary Carcinoma Caregiver
Ritchie Johnson is a Mother, Registered Nurse, Author, Speaker and Advocate.

Related Blog posts

Webinar: Radionuclide Diagnostics & Theranostics – Theory and Clinical Practice Meet!

Webinar: Radionuclide Diagnostics & Theranostics – Theory and Clinical Practice Meet!

Nuclear payloads, guided missiles, directed assassinations…not in global conflict or wars, but prostate cancer and what happens inside bodies of men getting radionuclide theranostics (treatment) and diagnostics (scanning) today.

Radionuclide treatment for prostate cancer is at least 10 years old – does that surprise you? Bayer’s Xofigo was approved in 2013 but adoption has been slow until recent FDA approvals of theranostics (treatment) viz. Pluvicto, and diagnostics (scans) like Illucix and Posluma.

Radionuclides are theory-intense with nuclear medicine doctors less exposed to  treatment of advanced prostate cancer. Conversely, GU medical oncologists are less familiar with radionuclides than hormone and chemo-therapy.

Two global experts, GU medical oncologist Dr. Oliver Sartor and nuclear medicine guru, Dr. Philip Kuo will introduce radionuclide theranostics and diagnostics and discuss how the clinic and the theory intersect. 

Webinar: Let’s Talk Medicare 2024

Webinar: Let’s Talk Medicare 2024

This could be scary…It’s almost open enrollment season for Medicare!

A dreaded time to receive multiple communications in untold ways that often read like a foreign language. It’s only fitting that we talked about it the day before Halloween.

Join AnCan as we bring experts Amanda Goodstadt, Esq. from Triage Cancer, and Medicare Insurance Broker Kim Umphres to explain all things confusing around 2024 Medicare insurance options, and make this enrollment season a little less spooky and intimidating.

Our services are free, but if you benefit then please consider a tax deductible donation. You can also support us by signing up to Amazon Smile and nominating Answer Cancer Foundation at no cost to you.

AnCan does not provide medical advice – we do empower you to manage your own care.

Our calls are recorded and posted on this website for later listening; please note we are a peer-to-peer support group and not subject to HIPAA compliance.